Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect.

MLA

Hu, Xiaoxia, et al. “Shikonin Reverses Cancer-Associated Fibroblast-Induced Gemcitabine Resistance in Pancreatic Cancer Cells by Suppressing Monocarboxylate Transporter 4-Mediated Reverse Warburg Effect.” Phytomedicine, vol. 123, Jan. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phymed.2023.155214.

APA

Hu, X., Peng, X., Zhang, Y., Fan, S., Liu, X., Song, Y., Ren, S., Chen, L., Chen, Y., Wang, R., Peng, J., Shen, X., & Chen, Y. (2024). Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect. Phytomedicine, 123, N.PAG. https://doi.org/10.1016/j.phymed.2023.155214

Chicago

Hu, Xiaoxia, Xiaoyu Peng, Yue Zhang, Shuangqin Fan, Xing Liu, Yuxuan Song, Shuang Ren, et al. 2024. “Shikonin Reverses Cancer-Associated Fibroblast-Induced Gemcitabine Resistance in Pancreatic Cancer Cells by Suppressing Monocarboxylate Transporter 4-Mediated Reverse Warburg Effect.” Phytomedicine 123 (January): N.PAG. doi:10.1016/j.phymed.2023.155214.